Today, the EVP & CFO of Torchmark, Frank Svoboda, exercised options of Torchmark for $1.08M.
Following Frank Svoboda’s last TMK Sell transaction on February 15, 2012, the stock climbed by 56.9%. In addition to Frank Svoboda, 3 other TMK executives reported Sell trades in the last month.
Based on Torchmark’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $1.06 billion and quarterly net profit of $1.03 billion. In comparison, last year the company earned revenue of $975 million and had a net profit of $135 million. The company has a one-year high of $93.60 and a one-year low of $73.99. TMK’s market cap is $9.97B and the company has a P/E ratio of 7.03.
11 different firms, including B.Riley FBR and Barclays, currently also have a Sell rating on the stock. Based on 4 analyst ratings, the analyst consensus is Moderate Sell with an average price target of $84.5, reflecting a 2.2% upside.
The insider sentiment on Torchmark has been negative according to 78 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Torchmark Corp. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Health Insurance, and Annuities. The Life Insurance segment involves in marketing, underwriting, and benefit administration of policies.